Follow this preprint
Appropriate relaxation of non-pharmaceutical interventions minimizes the risk of a resurgence in SARS-CoV-2 infections in spite of the Delta variant
View ORCID ProfileWadim Koslow, View ORCID ProfileMartin J. Kühn, View ORCID ProfileSebastian Binder, View ORCID ProfileMargrit Klitz, View ORCID ProfileDaniel Abele, View ORCID ProfileAchim Basermann, View ORCID ProfileMichael Meyer-Hermann
doi: https://doi.org/10.1101/2021.07.09.21260257
Now published in PLOS Computational Biology doi: 10.1371/journal.pcbi.1010054
Wadim Koslow
1Institute for Software Technology, Department of High-Performance Computing, German Aerospace Center, Cologne, Germany
Martin J. Kühn
1Institute for Software Technology, Department of High-Performance Computing, German Aerospace Center, Cologne, Germany
2Department of Systems Immunology and Braunschweig Integrated Centre of Systems Biology (BRICS), Helmholtz Centre for Infection Research, Braunschweig, Germany
Sebastian Binder
2Department of Systems Immunology and Braunschweig Integrated Centre of Systems Biology (BRICS), Helmholtz Centre for Infection Research, Braunschweig, Germany
Margrit Klitz
1Institute for Software Technology, Department of High-Performance Computing, German Aerospace Center, Cologne, Germany
Daniel Abele
1Institute for Software Technology, Department of High-Performance Computing, German Aerospace Center, Cologne, Germany
Achim Basermann
1Institute for Software Technology, Department of High-Performance Computing, German Aerospace Center, Cologne, Germany
Michael Meyer-Hermann
2Department of Systems Immunology and Braunschweig Integrated Centre of Systems Biology (BRICS), Helmholtz Centre for Infection Research, Braunschweig, Germany
![Loading Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Article usage
Picked up by 2 news outlets
Referenced in 1 policy documents
Tweeted by 24
Posted November 29, 2021.
Appropriate relaxation of non-pharmaceutical interventions minimizes the risk of a resurgence in SARS-CoV-2 infections in spite of the Delta variant
Wadim Koslow, Martin J. Kühn, Sebastian Binder, Margrit Klitz, Daniel Abele, Achim Basermann, Michael Meyer-Hermann
medRxiv 2021.07.09.21260257; doi: https://doi.org/10.1101/2021.07.09.21260257
Now published in PLOS Computational Biology doi: 10.1371/journal.pcbi.1010054
Subject Area
Subject Areas
- Addiction Medicine (408)
- Allergy and Immunology (719)
- Anesthesia (214)
- Cardiovascular Medicine (3035)
- Dermatology (258)
- Emergency Medicine (456)
- Epidemiology (12959)
- Forensic Medicine (12)
- Gastroenterology (848)
- Genetic and Genomic Medicine (4770)
- Geriatric Medicine (440)
- Health Economics (747)
- Health Informatics (3026)
- Health Policy (1095)
- Hematology (405)
- HIV/AIDS (951)
- Medical Education (450)
- Medical Ethics (119)
- Nephrology (490)
- Neurology (4544)
- Nursing (242)
- Nutrition (671)
- Oncology (2361)
- Ophthalmology (666)
- Orthopedics (264)
- Otolaryngology (332)
- Pain Medicine (296)
- Palliative Medicine (85)
- Pathology (512)
- Pediatrics (1229)
- Primary Care Research (515)
- Public and Global Health (7131)
- Radiology and Imaging (1586)
- Respiratory Medicine (940)
- Rheumatology (456)
- Sports Medicine (396)
- Surgery (503)
- Toxicology (63)
- Transplantation (218)
- Urology (187)